Abstract
The dosage and safety of botulinum toxin type A (BTX‐A) treatments in 104 children with cerebral palsy were examined in a retrospective chart review of a 2‐year period at Texas Scottish Rite Hospital for Children. Almost all of the BTX‐A injections were to the muscles of the lower limbs. The average dose of BTX‐A was 8–9 Ukg body weight and the interval between injections averaged 3–5 months. The average total amount of BTX‐A injected at a single visit ranged from 146 to 186 U. The safety record for these treatments was excellent, with only 14 adverse events reported in 257 patient injection visits. The most commonly reported adverse event was muscle weakness, which is related to the pharmacology of BTX‐A treatment
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
